Pharmaceutical & API manufacturing sites in Canada

205 drug establishments in Canada are registered with the US FDA; 34 (17%) list API manufacture among their operations. 175 registrant companies are identified, 2 of them with more than one API site here; sites whose registrant is not resolved to a company profile are not counted. 1 published site is matched to an EU or UK GMP certificate inspected within the last three years.

Counts are physical site addresses in the FDA's current establishment register (US-facing sites only), not headquarters and not production volume. Methodology

FDA-registered sites
205
Registered for API manufacture
34
Identified registrants
175
Current EU/UK GMP match
1

Only sites registered with the US FDA appear, so manufacturing that serves only other markets is missing and these figures understate national capacity. A GMP match requires the certificate address to name the site's street and its city or postcode; an unmatched site is not an uncertified site.